Are We at the Tipping Point for Personalized Medicine IVDS?

March 29, 2018 BACK TO RESOURCES

ADVI senior leaders discuss challenges and opportunities for molecular diagnostic tests in the context of Medicare’s recent national coverage determination and other developments.

Download full analysis here